Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Mike M who wrote (2095)	1/30/2000 12:45:00 AM
From: out_of_the_loop	Read Replies (1) \| Respond to of 5582

One of the things that management has proven with the deals that they have worked is that they are hard bargainers. Examples: Citadel - not floorless, gave warrants as an incentive, prohibited shorting, restricted the number of shares that could be put on the market daily, gave GumTech the choice of how to pay back loan (shares or cash) so as not to give an incentive to manipulate price lower and so as to (by warrants) have financier desire higher share price. Swedish Match - they give $10 million to start venture and GumTech still gets 49%. Zicam - GumTech has the option of buying out the rest of Gel Tech from BioDeliveries. Anyway, my point is that something favorable could be worked out if an offer were made - such as a spinoff of one of the ventures. We discussed that possibility a long time ago but nobody has talked about it much lately.